Search
for
Sort by
Research 31–60 of 1000+
- Actualités du SOPK
- Highlights from Recent Cancer Literature
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Transforming growth factor-β in stem cells and tissue homeostasis
- Assessment of Cytokine-Mediated Signaling Pathway Dysregulation in Arm Skin After CO2 Laser Therapy
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Molecular mechanisms of asymmetric divisions in mammary stem cells
- Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
- Antibody Drug Conjugates
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Redefining hormone resistance in prostate cancer
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- The evolution of primary multimodality treatment in resectable breast cancer
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Impact of Chemotherapeutic Drug on People living with Cancer
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Epigenetic regulation in adult stem cells and cancers
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Function of KLF4 in Stem Cell Biology
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion